I. Ergenc Et Al. , "Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients," Hepatology Forum , vol.5, no.3, pp.165-166, 2024
Ergenc, I. Et Al. 2024. Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients. Hepatology Forum , vol.5, no.3 , 165-166.
Ergenc, I., Gozaydinoglu, B., Keklikkiran, C., & YILMAZ, Y., (2024). Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients. Hepatology Forum , vol.5, no.3, 165-166.
Ergenc, Ilkay Et Al. "Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients," Hepatology Forum , vol.5, no.3, 165-166, 2024
Ergenc, Ilkay Et Al. "Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients." Hepatology Forum , vol.5, no.3, pp.165-166, 2024
Ergenc, I. Et Al. (2024) . "Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients." Hepatology Forum , vol.5, no.3, pp.165-166.
@article{article, author={Ilkay Ergenc Et Al. }, title={Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients}, journal={Hepatology Forum}, year=2024, pages={165-166} }